VictoriaPWerthMD

Dermatology • Philadelphia, PA

Dermatopathology

Professor of Dermatology, University Pennsylvania

Join to view full profile

Dr. Werth is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Werth's full profile

Already have an account?

Office
3400 Spruce Street
2 Rhoads Pavilion
Philadelphia, PA 19104
Phone+1 215-662-2737

Fax+1 215-349-8339
Is this information wrong?

Education & Training

NYU Grossman School of MedicineResidency, Dermatology, 1983 - 1986
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1980 - 1983
Johns Hopkins University School of MedicineClass of 1980

Certifications & Licensure

PA State Medical License 1989 - 2024
IL State Medical License 1982 - 1984
MD State Medical License 1980 - 1983
American Board of Dermatology Dermatology
American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Philadelphia Magazine Castle Connolly, 2008-2014
America's Top Doctors Castle Connolly, 2008-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Fellow (FAAD) American Academy of Dermatology
Top MD Consumers Checkbook
Super Doctor SuperDoctors.com
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

Use of Infliximab for the Treatment of Pemphigus Vulgaris Start of enrollment: 2006 Mar 01
Completed
Phase 2
Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris Start of enrollment: 1996 Nov 01
Terminated
Phase 2
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser Start of enrollment: 2007 Mar 01
Completed
Phase 2
Use of KC706 for the Treatment of Pemphigus Vulgaris Start of enrollment: 2007 Nov 01
Completed
Phase 2
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE) Start of enrollment: 2007 Nov 01
Completed
Not Applicable
Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus Start of enrollment: 2006 Dec 01
Recruiting
Photoprovocation Testing in Subjects With Cutaneous Lupus Start of enrollment: 2011 Dec 01
Completed
Not Applicable
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. Start of enrollment: 2013 Jul 01
Completed
Phase 1, Phase 2
Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis Start of enrollment: 2015 Jun 01
Terminated
Phase 2
Autoimmune Blistering Diseases Study Start of enrollment: 2016 Apr 01
Recruiting
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis Start of enrollment: 2018 Dec 17
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

The impact of hormones in autoimmune cutaneous diseases.
Lopes Almeida Gomes, L., Werth, A., Thomas, P., Werth, V.> ;The Journal of Dermatological Treatment. 2024 Dec 1
Response to: Correspondence on 'Current myositis clinical trials and tribulations' by Saygin.
Jin Kyun Park, Merrilee Needham, Ingrid E Lundberg, Didem Saygin, Victoria Werth, Julie J Paik, Lisa Christopher-Stine> ;Annals of the Rheumatic Diseases. 2024 Mar 28
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies ...
Alexander G S Oldroyd, Hector Chinoy, Patrick Gordon, Pedro M Machado, Neil McHugh, Albert Selva-O'Callaghan, Jens Schmidt, Sarah L Tansley, , Jeffrey P Callen, Lorind...> ;Nature Reviews. Rheumatology. 2024 Mar 28
Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lu...
Arianna J Zhang, Lourdes M Perez-Chada, Victoria P Werth, Joseph F Merola> ;Lupus Science & Medicine. 2024 Feb 26
Clinical characteristics and symptom progression of dermatomyositis subtypes: A retrospective analysis of a prospective database.
Pandya, R., Kleitsch, J., Lim, D., Werth, V.> ;Journal of the American Academy of Dermatology. 2024 Feb 9
1 citations
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132.
Burge, D., Posada, J., Werth, V., Boackle, S.> ;Lupus Science & Medicine. 2024 Feb 7
5th Global Conference on Myositis (GCOM).
Victoria Werth, Erin M Wilfong, Andrew L Mammen, Chester V Oddis, Didem Saygin, Vladimir M Liarski, Siamak Moghadam-Kia, Rohit Aggarwal, Dana P Ascherman> ;Clinical and Experimental Rheumatology. 2024 Feb 1
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank.
Aravinthan Loganathan, Giovanni Zanframundo, Akira Yoshida, Sara Faghihi-Kashani, Iazsmin Bauer Ventura, Eduardo Dourado, Francisca Bozan, Gianluca Sambataro, Yasuhiko...> ;Clinical and Experimental Rheumatology. 2024 Feb 1
1 citations
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
Didem Saygin, Stefanie Glaubitz, Rachel Zeng, Matteo Bottai, Marianne de Visser, Mazen M Dimachkie, David Fiorentino, Ingrid Gerhardson, Masataka Kuwana, Frederick W M...> ;Clinical and Experimental Rheumatology. 2024 Feb 1
1 citations
Current myositis clinical trials and tribulations.
Park, J., Needham, M., Lundberg, I., Saygin, D., Werth, V., Paik, J., Christopher-Stine, L.> ;Annals of the Rheumatic Diseases. 2024 Jan 12
Editorial: Cutaneous lupus erythematosus landscape: pathophysiology, unmet needs, and related challenges in clinical practice. What is on the horizon?
Joseph F Merola, Filippa Nyberg, Nathalie Franchimont, Catherine Barbey, Victoria P Werth> ;Frontiers in Medicine. 2024 Jan 1
2 citations
Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 IFN in Cutaneous Lupus: An In-Depth Immunoprofile of Subacute and Discoid Lupus.
Thomas Vazquez, Jay Patel, Nilesh Kodali, DeAnna Diaz, Muhammad M Bashir, Felix Chin, Emily Keyes, Meena Sharma, Grant Sprow, Madison Grinnell, Joshua Dan, Victoria P ...> ;The Journal of Investigative Dermatology. 2023 Dec 10
Overlap of dermatomyositis and cutaneous lupus erythematosus: A case series.
Pandya, R., Kleitsch, J., Lim, D., Werth, V.> ;JAAD Case Reports. 2023 Dec 1
1 citations
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initi...
Alexander G S Oldroyd, Jeffrey P Callen, Hector Chinoy, Lorinda Chung, David Fiorentino, Patrick Gordon, Pedro M Machado, Neil McHugh, Albert Selva-O'Callaghan, Jens S...> ;Nature Reviews. Rheumatology. 2023 Dec 1
Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis.
Julianne Kleitsch, Darosa Lim, Rachita Pandya, Victoria P Werth> ;JAAD Case Reports. 2023 Nov 1
1 citations
Emerging immunotherapeutic strategies for cutaneous lupus erythematosus: an overview of recent phase 2 and 3 clinical trials.
Darosa Lim, Julianne Kleitsch, Victoria P Werth> ;Expert Opinion on Emerging Drugs. 2023 Dec 1
Change in disease activity needed for meaningful change in cutaneous lupus by patient characteristic: A retrospective analysis of a longitudinal database.
Julianne Kleitsch, Rachita Pandya, Srita Chakka, Daisy Yan, Darosa Lim, DeAnna Diaz, Rui Feng, Victoria P Werth> ;Journal of the American Academy of Dermatology. 2024 Feb 1
Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis.
Lesley Ann Saketkoo, Antonia Valenzuela, Susan Kim, Liza J McCann, Christian Lood, Dawn M Wahezi, Victoria P Werth, Belina Yi, Helene Alexanderson, Susan Maillard, Cla...> ;Rheumatology. 2023 Jul 14
3 citations
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforce.
Kathryn Connelly, Laura E Eades, Rachel Koelmeyer, Darshini Ayton, Vera Golder, Rangi Kandane-Rathnayake, Kate Gregory, Hermine Brunner, Laurie Burke, Laurent Arnaud, ...> ;Nature Reviews. Rheumatology. 2023 Sep 1
Cigarette smoking is associated with decreased long-term treatment cessation of mycophenolate mofetil and methotrexate in cutaneous lupus erythematosus.
Henry W Chen, Grant Sprow, Rui Feng, Victoria P Werth, Benjamin F Chong> ;Lupus. 2023 Aug 1
1 citations
Validation of Cutaneous Dermatomyositis Disease Area and Severity Index Activity Score and Other Efficacy Outcomes as Measures of Skin Disease in Dermatomyositis in th...
Rachita Pandya, Joshua Dan, Julianne Kleitsch, Barbara White, Victoria P Werth> ;The Journal of Investigative Dermatology. 2023 Dec 1
1 citations
A comparison of the efficacy of Skindex-16 and Skindex-29 in dermatomyositis.
Joshua Dan, Grant Sprow, Josef Concha, Jay Patel, Nilesh Kodali, DeAnna Diaz, Thomas Vazquez, Victoria P Werth> ;The British Journal of Dermatology. 2023 Jul 17
The Importance of Patient-Focused Drug Development in Pemphigus and Pemphigoid.
Marc Yale, Patrick Dunn, Rebecca Strong, Isobel Davies, Laurence Gallu, Pascal Joly, Dedee F Murrell, Victoria P Werth, Aimee S Payne> ;The Journal of Investigative Dermatology. 2023 Oct 1
The physical and emotional impact of cutaneous dermatomyositis: a qualitative study.
Julianne Kleitsch, Jeffrey D Weiner, Rachita Pandya, Josef S Concha, Darosa Lim, Victoria P Werth> ;Archives of Dermatological Research. 2023 Oct 1
Trial of intravenous immunoglobulin in dermatomyositis: a critically appraised research paper.
Rachita Pandya, Julianne Kleitsch, Victoria P Werth> ;The British Journal of Dermatology. 2023 May 24
Join now to see all

Journal Articles

Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus
Scott A Elman, Kara Braudis, Hee Joo Kim, Victoria P Werth, JAMA Dermatology
Fatigue in Systemic Lupus Erythematosus and Other Autoimmune Skin Diseases
V P Werth, D Pearson, C J Kushner, The British Journal of Dermatology
Systemic Sclerosis: Current Concepts of Skin and Systemic Manifestations
David R Pearson, Victoria P Werth, ScienceDirect
Evaluation of the Reliability and Validity of the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) in Pediatric Cutaneous Lupus Among Pediatric De...
P J Kahn, D R Pearson, B Patel, V P Werth, Y E Chiu, The British Journal of Dermatology
Systemic Sclerosis: Current Concepts of Skin and Systemic Manifestations
David R Pearson, Victoria P Werth, Lisa Pappas-Taffer, Clinics in Dermatology
Prevalence of Pruritus in Cutaneous Lupus Erythematosus: Brief Report of a Multicenter, Multinational Cross-Sectional Study
Victoria Werth, MD, Hindawi
The CLASI (Cutaneous LE Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus
Albrecht J, Taylor L, Berlin J, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G , McGinnis K, Richardson S, Treat J, Vittorio C, Voorhees AV, Werth VP, Journal of Investigative Dermatology, 2005
Join now to see all

Lectures

Recent Advances in Bullous Diseases
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019

Authored Content

Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020

Press Mentions

Hottest Topics of the 2023 AAD Annual MeetingMarch 27th, 2023
Cannabinoid Receptor Agonist Shows Promise for Autoimmune Condition TreatmentSeptember 27th, 2022
Lenabasum, a Cannabinoid Receptor Agonist, Is an Effective and Safe Treatment for Amyopathic DermatomyositisSeptember 21st, 2022
Join now to see all

Grant Support

Patient-Oriented Research In Skin Autoimmune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2012
Assess The Safety Of Pi-0824 In Patients With Pemphigus VulgarisNational Center For Research Resources2005
Patient-Oriented Research In Skin Autommune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2005